NYSSA • The New York State Society of Anesthesiologists, Inc.
Volume 75 Number 4
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of drugs approved by the Food and Drug Administration for treatment of type 2 diabetes mellitus, but they have recently emerged as a common (and even fashionable) drug for weight loss.
You'll have to be logged in to keep reading.
Website design, development and hosting by MAjor Designs